Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassam Atallah

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|April 30, 2020
A marker of systemic inflammation or direct cardiac injury: should cardiac troponin levels be monitored in COVID-19 patients?Bassam Atallah, Saad I Mallah, Laila AbdelWareth, et al.
Heart Failure Reviews|February 7, 2017
Heart failure in the elderly: ten peculiar management considerationsFeras Bader, Bassam Atallah, Lisa F Brennan, et al.
Frontiers in Cardiovascular Medicine|March 5, 2025
Ischemia with no obstructed coronary arteries and microvascular testing procedures: a review of utility, pharmacotherapy, and current challengesMohammad Al Bitar, Ronney Shantouf, Ashraf Al Azzoni, et al.
Clinical Nephrology|January 12, 2023
Polypharmacy in cardiorenal syndrome patientsShahrukh Hashmani, Rakesh Madhyastha, Wasim El Nekidy, et al.
Journal of Thrombosis and Thrombolysis|April 25, 2023
Anticoagulation practices and complications associated with Impella® support at an advanced cardiac center in the Middle East gulf regionMohamed Hisham, Hussam H Ghalib, Vivek Kakar, et al.
Journal of Thrombosis and Thrombolysis|October 4, 2020
Thromboelastography findings in critically ill COVID-19 patientsNouran Salem, Bassam Atallah, Wasim S El Nekidy, et al.
Frontiers in Cardiovascular Medicine|April 3, 2026
Low dose slow and ultraslow thrombolytic therapy for patients with prosthetic valve thrombosis: a pharmacist-led protocol experience from a Middle Eastern quaternary care centerZiad Sadik, Khaled Al Zaman, Emna Abidi, et al.
Thrombosis Journal|September 14, 2020
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markersBassam Atallah, Wasim El Nekidy, Saad I Mallah, et al.
Progress in Cardiovascular Diseases|March 25, 2020
Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathySaad I Mallah, Bassam Atallah, Fathi Moustafa, et al.
Journal of Cardiovascular Pharmacology|September 14, 2020
Appropriateness of the Direct Oral Anticoagulants Dosing in the Middle East Gulf RegionZohour Anouassi, Bassam Atallah, Leen Oyoun Alsoud, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
European Heart Journal. Quality of Care & Clinical Outcomes|April 30, 2020
A marker of systemic inflammation or direct cardiac injury: should cardiac troponin levels be monitored in COVID-19 patients?Bassam Atallah, Saad I Mallah, Laila AbdelWareth, et al.
Heart Failure Reviews|February 7, 2017
Heart failure in the elderly: ten peculiar management considerationsFeras Bader, Bassam Atallah, Lisa F Brennan, et al.
Frontiers in Cardiovascular Medicine|March 5, 2025
Ischemia with no obstructed coronary arteries and microvascular testing procedures: a review of utility, pharmacotherapy, and current challengesMohammad Al Bitar, Ronney Shantouf, Ashraf Al Azzoni, et al.
Clinical Nephrology|January 12, 2023
Polypharmacy in cardiorenal syndrome patientsShahrukh Hashmani, Rakesh Madhyastha, Wasim El Nekidy, et al.
Journal of Thrombosis and Thrombolysis|April 25, 2023
Anticoagulation practices and complications associated with Impella® support at an advanced cardiac center in the Middle East gulf regionMohamed Hisham, Hussam H Ghalib, Vivek Kakar, et al.
Journal of Thrombosis and Thrombolysis|October 4, 2020
Thromboelastography findings in critically ill COVID-19 patientsNouran Salem, Bassam Atallah, Wasim S El Nekidy, et al.
Frontiers in Cardiovascular Medicine|April 3, 2026
Low dose slow and ultraslow thrombolytic therapy for patients with prosthetic valve thrombosis: a pharmacist-led protocol experience from a Middle Eastern quaternary care centerZiad Sadik, Khaled Al Zaman, Emna Abidi, et al.
Thrombosis Journal|September 14, 2020
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markersBassam Atallah, Wasim El Nekidy, Saad I Mallah, et al.
Progress in Cardiovascular Diseases|March 25, 2020
Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathySaad I Mallah, Bassam Atallah, Fathi Moustafa, et al.
Journal of Cardiovascular Pharmacology|September 14, 2020
Appropriateness of the Direct Oral Anticoagulants Dosing in the Middle East Gulf RegionZohour Anouassi, Bassam Atallah, Leen Oyoun Alsoud, et al.
Pageof 4